Health Sciences Group Inc. Stock Analysis HESG
Health Sciences Group, Inc. engages in the development of healthcare mobile applications. The company is headquartered in Los Angeles, California. The company went IPO on 2001-08-03. The firm has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The firm will launch its new product, Sequesterol Advance Cardio Formula in April 2006.
Read More Health Sciences Group Inc (HESG) Chart
Key Statistics of Health Sciences Group Inc (HESG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
100.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
18.71KAvg. Volume
972.27KDividend Yield
-Financial Metrics & Statements of Health Sciences Group Inc (HESG)
FAQ's for Health Sciences Group Inc (HESG)
- According to Musaffa’s Shariah screening methodology, Health Sciences Group Inc (HESG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.